These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6441856)

  • 41. Alloimmunization in pregnancy during the years 1992-2005 in the central west region of Sweden.
    Gottvall T; Filbey D
    Acta Obstet Gynecol Scand; 2008; 87(8):843-8. PubMed ID: 18704776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noninvasive fetal Rh genotyping: the time has come.
    Queenan JT
    Obstet Gynecol; 2005 Oct; 106(4):682-3. PubMed ID: 16199621
    [No Abstract]   [Full Text] [Related]  

  • 43. The prevention of erythroblastosis.
    Appl Ther; 1970 Jul; 12(7):5 passim. PubMed ID: 4991088
    [No Abstract]   [Full Text] [Related]  

  • 44. [The Kleihauer test and directed prevention of hemolytic disease of the newborn due to materno-fetal Rh-factor isoimmunization. Preventive note].
    De Luca P; Adinolfi G; Corbo M
    Minerva Ginecol; 1980 Dec; 32(12):1179-81. PubMed ID: 6793940
    [No Abstract]   [Full Text] [Related]  

  • 45. [Successively improved prognosis in erythrocyte immunization].
    Westgren M; Bui TH; Grunewald C; Kublickas M; Kalsson A; Wolff K; Shanwell A
    Lakartidningen; 1998 May; 95(22):2594-9. PubMed ID: 9640939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rh-immunoglobulin: Rh prophylaxis.
    Bowman J
    Best Pract Res Clin Haematol; 2006; 19(1):27-34. PubMed ID: 16377539
    [No Abstract]   [Full Text] [Related]  

  • 48. Controversies in Rh prophylaxis.
    Hensleigh PA
    Am J Obstet Gynecol; 1985 Sep; 153(1):112-3. PubMed ID: 2994476
    [No Abstract]   [Full Text] [Related]  

  • 49. [What will happen to the Rh prophylaxis?].
    Björnståhl H
    Lakartidningen; 1999 Apr; 96(17):2069. PubMed ID: 10354666
    [No Abstract]   [Full Text] [Related]  

  • 50. Historical perspective of Rh disease in Nebraska (1973-1982): profile of Rh negative women delivering live newborns.
    Grant RS; Field CA; Woods RE
    Nebr Med J; 1989 Dec; 74(12):360-3. PubMed ID: 2514383
    [No Abstract]   [Full Text] [Related]  

  • 51. Diagnosis, prevention, and therapy in hemolytic disease of the newborn.
    Polesky HF
    Clin Lab Med; 1982 Mar; 2(1):107-22. PubMed ID: 6821161
    [No Abstract]   [Full Text] [Related]  

  • 52. [Prevention of Rh immunization. I. Theoretical background and management of the risk during the first half of pregnancy].
    Larsen JF; Bock JE; Jørgensen JR
    Ugeskr Laeger; 2004 Aug; 166(36):3073-8. PubMed ID: 15387303
    [No Abstract]   [Full Text] [Related]  

  • 53. [Value of RHD fetal genotyping in the prevention of anti-D immunization].
    Brossard Y; Sender A; Cartron JP; Huchet J; Pinon F; Blot P; David G
    Bull Acad Natl Med; 2001; 185(2):329-36. PubMed ID: 11474588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of rhesus isoimmunization.
    Am J Obstet Gynecol; 1984 Apr; 148(8):1151-3. PubMed ID: 6424479
    [No Abstract]   [Full Text] [Related]  

  • 55. [Rh isoimmunization in a primigravida sensitized by hemotherapy].
    Marsico S; Di Martino D
    Arch Ostet Ginecol; 1965; 70(3):243-6. PubMed ID: 5836883
    [No Abstract]   [Full Text] [Related]  

  • 56. [Rh-prophylaxis or not? Obstetric departments should make decisions if there are medical reasons which justify the treatment].
    Messeter L
    Lakartidningen; 2000 Dec; 97(51-52):6030-3. PubMed ID: 11195439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prevention and management of haemolytic disease of the newborn.
    Contreras M; de Silva M
    J R Soc Med; 1994 May; 87(5):256-8. PubMed ID: 8207718
    [No Abstract]   [Full Text] [Related]  

  • 58. Managing a pregnancy with antibodies: a clinician's perspective.
    Tarsa M; Kelly TF
    Immunohematology; 2008; 24(2):52-7. PubMed ID: 19852131
    [No Abstract]   [Full Text] [Related]  

  • 59. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 60. [RCP: prevention in materno-fetal Rh immunization (CNGOF, December 2005). We don't have to forget to control the efficacy of these guidelines, as well as the prescription of the innovating technique in this field].
    Sagot P
    Gynecol Obstet Fertil; 2006 Apr; 34(4):358-9. PubMed ID: 16603404
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.